Justin Cidado
7PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 19, 2024
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.Sankaranarayanan Kannan, Yizhen Li, Natalia Baran
|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu
|Jan 26, 2021
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy.Claire M Patterson, Srividya B Balachander, Iain Grant
|Dec 01, 2020
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.Scott Boiko, Theresa Proia, Maryann San Martin
|Sep 29, 2020
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Srividya B Balachander, Steven W Criscione, Kate F Byth
|Nov 09, 2019
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells.Justin Cidado, Scott Boiko, Theresa Proia
Pageof 2
Frequent Collaborators
2 joint publications
William McCoull
2 joint publications
Omid Tavana
2 joint publications
Mathew J Garnett
2 joint publications
Patricia Jaaks
2 joint publications
Elizabeth A Coker
2 joint publications
Courtney L Andersen
2 joint publications
Francis D Gibbons
1 joint publications
David M Weinstock
1 joint publications
Kate F Byth
1 joint publications
Shenghua Wen
